| Product Code: ETC8283634 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Molecular Point of Care Testing (using NAAT) Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Molecular Point of Care Testing (using NAAT) Market - Industry Life Cycle |
3.4 Mexico Molecular Point of Care Testing (using NAAT) Market - Porter's Five Forces |
3.5 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Mexico Molecular Point of Care Testing (using NAAT) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Mexico |
4.2.2 Growing demand for rapid and accurate diagnostic solutions |
4.2.3 Technological advancements in molecular point of care testing (using NAAT) |
4.3 Market Restraints |
4.3.1 High cost associated with molecular point of care testing technology |
4.3.2 Limited access to advanced healthcare facilities in certain regions of Mexico |
4.3.3 Stringent regulatory requirements for approval and adoption of NAAT-based tests |
5 Mexico Molecular Point of Care Testing (using NAAT) Market Trends |
6 Mexico Molecular Point of Care Testing (using NAAT) Market, By Types |
6.1 Mexico Molecular Point of Care Testing (using NAAT) Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2 Mexico Molecular Point of Care Testing (using NAAT) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Respiratory Infections Testing, 2021- 2031F |
6.2.3 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Sexually Transmitted Infection (STI) Testing, 2021- 2031F |
6.2.4 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Gastrointestinal Tract Infections Testing, 2021- 2031F |
6.2.5 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Molecular Point of Care Testing (using NAAT) Market, By End users |
6.3.1 Overview and Analysis |
6.3.2 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.3 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.5 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Ambulatory Centers, 2021- 2031F |
6.3.6 Mexico Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Molecular Point of Care Testing (using NAAT) Market Import-Export Trade Statistics |
7.1 Mexico Molecular Point of Care Testing (using NAAT) Market Export to Major Countries |
7.2 Mexico Molecular Point of Care Testing (using NAAT) Market Imports from Major Countries |
8 Mexico Molecular Point of Care Testing (using NAAT) Market Key Performance Indicators |
8.1 Adoption rate of molecular point of care testing in healthcare facilities |
8.2 Rate of investment in research and development for NAAT technology |
8.3 Number of partnerships and collaborations between healthcare providers and technology companies for molecular point of care testing |
9 Mexico Molecular Point of Care Testing (using NAAT) Market - Opportunity Assessment |
9.1 Mexico Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Mexico Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Mexico Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Mexico Molecular Point of Care Testing (using NAAT) Market - Competitive Landscape |
10.1 Mexico Molecular Point of Care Testing (using NAAT) Market Revenue Share, By Companies, 2024 |
10.2 Mexico Molecular Point of Care Testing (using NAAT) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here